Large-scale preparation of thrombin from human plasma

Thrombosis Research

Volumn 122, Issue 4, 2008, Pages 560-567

  Aizawa, Peter ^a   Winge, Stefan ^a   Karlsson, Göran ^a  

^a Octapharma AB   (Sweden)

Author keywords

Fibrin glue; Fibrin sealant; Prothrombin; Thrombin

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 9; FIBRIN GLUE; PROTHROMBIN; THROMBIN;

ARTICLE; CHROMATOGRAPHY; COST EFFECTIVENESS ANALYSIS; CRYOPRECIPITATION; HEPARIN AFFINITY CHROMATOGRAPHY; HUMAN; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; ION EXCHANGE CHROMATOGRAPHY; NANOFILTRATION; PLASMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SEPARATION TECHNIQUE; ULTRAFILTRATION;

EID: 48049092347     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.12.027     Document Type: Article

References (31)

1. Fenton II J.W., Fasco M.J., and Stackrow A.B. Human thrombins: production, evaluation, and properties of α-thrombin. J Biol Chem 252 (1977) 3587-3598
2. Fenton II J.W., Ofosu F.A., Moon D.G., and Maraganore J.M. Thrombin structure and function: why thrombin is the primary target for antithrombotics. Blood Coagul Fibrinolysis 2 (1991) 69-75
3. Stearns-Kurosawa D.J., Kurosawa S., Mollica J.S., Ferrell G.L., and Esmon C.T. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci USA 93 (1996) 10212-10216
4. Chang J.Y. The structures and proteolytic specificities of autolyzed human thrombin. Biochem J 240 (1986) 797-802
5. Miller-Andersson M., Gaffney P.J., and Seghatchian M.J. Preparation and stability of a highly purified human thrombin standard. Thromb Res 20 (1980) 109-122
6. Glover G., and Shaw E. The purification of thrombin and isolation of a peptide containing the active center histidine. J Biol Chem 246 (1971) 4594-4601
7. Chabbat J., Tellier M., Porte P., and Steinbuch M. Properties of a new fibrin glue stable in liquid state. Thromb Res 76 (1994) 525-533
8. Lundblad R.L., Tsai J., Wu H.F., Jenzano J.W., White II G.C., and Connolly T.M. Hydrophobic affinity chromatography of human thrombin. Arch Biochem Biophys 302 (1993) 109-112
9. Metzner H, Heinrich S. Thrombin preparations and process for their production. Patent application US-2001-0033837, published 2001.
10. Husi H., and Walkinshaw M.D. Separation of human vitamin K-dependent coagulation proteins using hydrophobic interaction chromatography. J Chromatogr B 736 (1999) 77-88
11. Wu H., and Bruley D.F. Homologous human blood protein separation using immobilized metal affinity chromatography: protein C separation from prothrombin with application to the separation of factor IX and prothrombin. Biotechnol Prog 15 (1999) 928-931
12. Burnouf T., and Radosevich M. Reducing the risk of infection from plasma products: specific preventative strategies. Blood Rev 14 (2000) 94-110
13. Winge S, Aizawa P. Prothrombin purification. Patent application WO-2004-050904, published 2004.
14. Winge S, Aizawa P, Karlsson G. Process for preparating concentrated thrombin solutions and use in fibrin glue. Patent application, WO-2004-050700, published 2004.
15. Lundblad R.L., Bradshaw R.A., Gabriel D., Ortel T.L., Lawson J., and Mann K.G. A review of the therapeutic uses of thrombin. Thromb Haemost 91 (2004) 851-860
16. Andersson L, Borg H, Miller-Andersson M, Hanshoff G, Lindroos G, Ehrenberg G, Forsman N. Isolation of coagulation factors from biological material. Patent, ZA7403896, published 1975.
17. Horowitz B., Bonomo R., Prince A.M., Chin S.N., Brotman B., and Shulman R.W. Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma. Blood 79 (1992) 826-831
18. Seegers W.H. Activation of purified prothrombin. Proc Soc Exp Biol Med 72 (1949) 677-680
19. Teng C.M., and Seegers W.H. Activation of factor X and thrombin zymogens in 25% sodium citrate solution. Thromb Res 22 (1981) 203-212
20. Kaetsu H., Mizuguchi J., Hamamoto T., Kamimura K., Yoshida Y., Nakagaki T., Ogata Y., Miyamoto S., and Funatsu A. Large-scale preparation of human thrombin: polyethylene glycol potentiates the factor Xa-mediated activation of prothrombin. Thromb Res 90 (1998) 101-109
21. Product information for 10% SDS-PAGE, NuPAGE Bis-Tris gels (No. NP0301BOX). Invitrogen, Carlsbad, CA, USA.
22. Johansson S., and Skoog B. Rapid silver staining of polyacrylamide gels. J Biochem Biophys Meth 14 Suppl. (1987) 33
23. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 17 (1957) 237-246
24. Aurell L., Friberger P., Karlsson G., and Claeson G. A new sensitive and highly specific chromogenic peptide substrate for factor Xa. Thromb Res 11 (1977) 595-609
25. Axelsson G., Korsan-Bengtsen K., and Waldenstrom J. Prothrombin determination by means of a chromogenic peptide substrate. Thromb Haemost 36 (1976) 517-524
26. Karlsson G. Analysis of human α-thrombin by hydrophobic interaction high-performance liquid chromatography. Protein Expr Purif 27 (2003) 171-174
27. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83 (1977) 346-356
28. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
29. Boissel J.P., Le Bonniec B., Rabiet M.J., Labie D., and Elion J. Covalent structures of β and γ autolytic derivatives of human alpha-thrombin. J Biol Chem 259 (1984) 5691-5697
30. Kosow D.P., Morris S., Orthner C.L., and Rhee M.J. Use of size-exclusion high-performance liquid chromatography for the analysis of the activation of prothrombin. Anal Biochem 126 (1982) 425-432
31. Burnouf T., and Radosevich M. Nanofiltration of plasma-derived biopharmaceutical products. Haemophilia 9 (2003) 24-37